S100A9 and neoplasm: Extracellularly, S100A8/S100A9 heterodimer fulfils the characteristics of a DAMP (49) and binding with RAGE, through MAPK pathway, contributes to the viability and migration of tumor cells in a concentration-dependent manner (51).